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Introduction: Anxiety is a generalized and extremely unpleasant feeling of vague dread of 
unknown origin which is accompanied by physical feelings like exhaustion, chest tightness, 
palpitations, sweating, headache, sudden desire to urinate, restlessness, and a desire to move. 
Anxiety is one of the most common psychiatric disorders which lead to problems in many 
aspects of individual, family, and social life. According to some studies, one out of every four 
people experiences a type of an anxiety disorder in lifetime. Medicinal plants play an 
important role in treating the disease and they cause milder symptoms in comparison with 
chemical drugs. Hence in this research, the anxiolytic effect of the extract of winter cherry 
(Withania somnifera) was compared with the effect of diazepam which is a chemical drug. 
Materials and methods: After extraction of essence from the roots of the plant, the collected 
root extract was injected intraperitoneally with doses of 150, 100, 75, 50, and 25،mg/kg.  
Diazepam was injected with a dose of 1 mg/kg and the same volume of saline was also 
injected 30 min before assessing anxiolytic effects. Plus-maze apparatus was used to study 
animal behavior. 
Results: The largest and the smallest amount of OAT were attributed to doses of150 mg/kg 
and 25 mg/kg, respectively. The best dose of root extract was 75 mg / kg,becausehigher 
amounts of the root extract did not result in a significant difference.  
Conclusion: Winter cherry root extract reduces anxiety, and a dose of 75 mg/kg generated an 
effect similar to that of diazepam. However, it reduced locomotor activity. 
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Introduction 
Herbal medicine has been used for 
thousands of years as an alternative 
method of medicine. Supply and demand 
for medicinal plants is increasing annually. 
In the Declaration of Alma-Ata in 1978, 
World Health Organization (WHO) noted 
that a large number of people believe in 
herbal medicines and use them for their 
own health care. Accordingly, the use of 
herbal medicines and more generally the 
traditional medicines was included in 
public health program in 2000 (1). 
Bozidan (Withania somnifera) is a plant 
with several important medicinal 
properties. This herb has anti-
inflammatory, anti-anxiety effects; it 
facilitates the normal functioning of liver 
and relieves the mucus secretions. In 
recent years, it has been proved that the 
plant can be used for the treatment or cure 
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of asthma, ulcers, insomnia, bronchitis, 
pulmonary tuberculosis, rheumatism, 
excessive thinness, dementia in old ages, 
and stroke (2). The results of different 
researches show that this plant is helpful 
for relieving anxiety, cognitive disorders, 
and some neurological disorders (3). 
Bozidan, as an adaptogen, is applied for 
patients with fatigue (with an origin of 
nervous exhaustion) and disability caused 
by mental and physical stress; it has 
immune stimulating properties which is 
useful for patients suffering from severe 
reduction in white blood cell count (4). 
The maximum dose is 5 mg and it should 
be administered under medical 
supervision. The plant has slim and 
smooth cylindrical roots with a light cream 
color; its interior part is white and tastes 
bitter mucilage. The local names of the 
bush are “Kopinak, Boodmar, Lakri, 
Lalehbar, and Shokran.” The scientific 
name of the plant is Withania somnifera 
and it is from dark potatoes (Solanaceae) 
family (2). 
It is an upright shrub with radiating 
branches, white colored, and is all downy. 
Its flowers are yellow - green and it has 
round and yellow berry fruit which turns 
black after drying. In early summer, the 
fruit reaches its fruition. The plant has a 
fleshy and green leaf which protects soil 
from storms. Its leaves are leathery, tough, 
and spear-like (5). The plant is found in 
dried parts of India and the Himalayas at 
an altitude of over 1700 meters. In Iran, 
this plant is native to the South East parts 
of the country and is among the plants 
commonly grown in the city of Saravan, 
Iranshahr, Soldier, Sib, Suzan, Zabol, and 
the vicinity of Zahedan especially 
Askolabad; it generally grows in plains 
and mountains (hillsides) (3).  
Chemical constituents: The plant contains 
a bitter alkaloid (Somniferin) with a 
sedating effect and it has resins, fats, and 
pigments. Glucose-lowering, plant sterol, 
eiporanol mixture of saturated and 
unsaturated fatty acids, a small amount of 
main the alkaloid nicotine, somniferin , 
withanine, withania, and a withanine -like 
substance have been extracted from the 
plant so far (2). 
Simmon et al. in 1994 concluded that beta 
amyloid is an important pathological factor 
which induces Alzheimer disease and it 
induced the arrangements of beta sheet in 
brain that causes the death of nerve cells in 
the brain (6). Koboyama in 2002 
concluded that withanolide A could be 
obtained from methanol extract of winter 
cherry and could repair the damage caused 
by amyloid beta in the cerebellar cortex 
and hippocamp. (6). The National 
Research Institute of the United States, in 
2002, announced that 8.5% of people in 
the United States have at least once tried 
anxiolytic drugs. Benzodiazepines misuse 
among psychiatric patients and those who 
abuse substances is 23% more than normal 
people (7). Due to the side effects of 
chemical drugs, this study assessed the 
anxiolytic effect of winter cherry 
(Withania somnifera) compared with the 
effect of diazepam as a chemical drug. 
Materials and methods 
In this study we used large laboratory rats 
(adult male Wistar rats) with an average 
weight of 200-250 grams. The animals 
were purchased from Razi Institute, Karaj. 
The physical condition of the place where 
the animals were kept was as follows: 
housed with a 12-h light/dark cycle and a 
temperature of 22 ± 2°C without noise. 
The animals were fed using special rats’ 
food (pellets) produced by Pars Poultry 
feed Corporation.  
Extraction: An adequate amount of winter 
cherry (Bozidan) root was purchased from 
traditional pharmacies of the city of Qom. 
After grinding and powdering the dried 
root of the plant, it was soaked for 72 
hours in 70% ethanol. The ethanol was 
separated in a rotary device. Then, the 
moisture content was determined and it 
was applied in specific doses. 
Experimental groups: 42 male Wistar rats 
were divided into seven groups of six. One 
control group, five groups of root extract 




with doses of 150, 100, 75, 50, and 25 
mg/kg, and one group of diazepam with a 
dose of 1 mg/kg were injected 
intraperitoneally half an hour before taking 
the test. 
Behavioral tests: Plus-maze device was 
used for the assessment of fear behavior. 
The standard Plus-maze device is designed 
to determine the level of fear and anxiety 
in rats. It is made of wood and it has two 
open arms and two closed arms; the closed 
arms have tall walls. Each open and closed 
arm has a dimension of 10 × 50 cm; there 
is a wall of 40 cm height at the two ends of 
closed arm and there is an edge of 1 cm at 
end of the open arm made of glass. Closed 
arm represents security and open arm 
indicates exploratory activity. Five 
minutes after injection of the extract, mice 
are placed in a central area of the device. 
During five minutes, when the animals 
could move freely through the maze, the 
following parameters were measured with 
a stopwatch through observations. 
 -Number of entry into the open arms 
compared with entry into the open and 
closed arms (OAE) 
 -Time spent in the open arm compared
 with the total time of the trial (OAT) 
- The number of times animals entered the 
opens and closed arm (locomotor activity) 
Statistical analysis 
Statistical analysis was performed using 
SPSS software via one-way-ANOVA and 
post hock Tukey tests. The results of 
statistical analysis are shown as mean ± 
SD. 
Results 
Figures obtained from the statistical results 
showed significant mean differences 
between the experimental and control 
groups. As shown in Figure (1) the 
maximum value of OAT (time spent in 
open arm) was observed at a dosage of 159 
mg/kg (91.7%) and then at doses of 100 
and 75 mg/kg, respectively. The minimum 
value for this variable (16.72%) was 
observed in the control group. Thus, it can 
be concluded that the least level of anxiety 
was observed in rats that were in the 
treatment of 150 mg / kg dosage, and the 














               
                Figure 1. Comparison of the average OAT, which is plotted based on the Mean ± SEM. 
               *P <005, **P <0.01, and ***P <o.oo1                     
  




According to the chart (2) ,  the maximum 
value of OAE (the number of open arm 
entries) was observed in a dose of 150 
mg/kg  (77.22%), the next maximum 
values were observed in the group 
receiving a dosage of 75 mg/kg and the 
group receiving diazepam, respectively. 
The lowest level (28.7%) was observed in 



















                 Figure 2. Comparison of the average OAE, which is plotted based on the Mean ± SEM. 
                 *P <005,    **P <0.01, and ***P <o.oo1 
 
Considering diagram (3), the maximum 
value of the variable CAT (time spent in 
the closed arm) was observed in the 
control group (83.27%) and then in the 
groups receiving doses of 50 and 25 
mg/kg. The minimum value (29.8%) was 
observed in the group receiving a dose of 
150 mg/kg. So the maximum anxiety was 
observed in the control group, and the 
minimum level of anxiety was observed in 















                 Figure 3. Comparison of the average CAT, which is plotted based on the Mean ± SEM.  
                 *P <005,    **P <0.01, and ***P <o.oo1 
 




According to the diagram (4), the 
maximum value of CAE (number of 
closed arm entries) was observed in a dose 
of 25 mg/kg (71.92%) and then in a dose 
of 50 mg/kg. The lowest value (22.77%) 











                 Figure 4. Comparison of the average CAE, which is plotted based on the Mean ± SEM.  
                 *P <005,    **P <0.01, and ***P <o.oo1 
 
According to the diagram (5), the 
maximum locomotor activity was 
observed in a dose of 50 mg/kg  (10.83 
times) and the minimum level was 
observed in a dose of 150 mg/kg, i.e. with 
an increase in the dosage of extract, the 
values of these variable declined and rats 









           Figure 4: Comparison of the average locomotor activity, which is plotted based on theMean ± SEM.         
           *P <005,    **P <0.01, and ***P <o.oo1 
 
Considering the mean values of the 
variables and since the mean variable was 
lower in a dose of 25 mg/kg, it can be 
concluded that the level of anxiety 
decreased with an increase in the use of 
the extract or diazepam the level of anxiety 
decreased. In a dose of 50 mg/kg, there 
was an increase in OAT values with an 




increase in the use of extract or drug there 
was an increase in OAT values, while 
there was a decrease in anxiety. However, 
increasing the doses above 75 mg/kg (i.e. 
the doses of 100 and 150 mg/kg or while 
using diazepam) for the treated samples 
did not make any significant change in 
OAT variable.  Therefore, the best dosage 
of winter cherry root extract in wistar rats 
is 75 mg/kg, and increasing the dosage 
will cause no significant change. 
Conclusion 
Anxiety disorders are one of the most 
common mental disorders and are the 
major common cause of patients’ 
admission to psychiatric clinics. Although 
several different medicinal and non-
medicinal methods have been developed to 
control anxiety, yet there are many 
different people are still suffering people 
suffer from anxiety for a variety of 
reasons. It seems that there is a long way 
away facing mankind to control this 
personal and social problem (8). It is quite 
clear for everybody that traditional 
medicine and medicinal plants play a 
special role in treating diseases. The 
effective ingredients in medicinal plants 
are accompanied by other substances 
which make a biological balance and 
therefore they are not accumulated in the 
body and they have fewer side effects (9). 
Diazepam, as a benzodiazepine drug, on 
the one hand has proven soothing effect on 
the central nervous system and on the 
other hand it is considered as an anxiolytic 
drug. Diazepam causes palliative and 
anxiolytic effects through an interaction 
with GABA receptors in brain especially 
the brain, especially the midbrain reticular 
system, causes palliative and anxiolytic 
effects (10). 
Bozidan dose-dependent treatment leads to 
a reduction in the activity of glutathione 
peroxidase and inhibits lipid peroxidation 
and protein peroxidation induced by 
copper in small mice. Accordingly, it can 
be effective in maintaining physical and 
mental health. Furthermore, the results of 
clinical and laboratory studies on animal 
models showed that this plant can be 
effective in treating anxiety and cognitive 
disorders (3). The study conducted in 
Pharmacology ward, Health Science 
Center of University of Texas indicated 
that extracts of this plant has a GABA-like 
activity; so, it is probably is effective in 
reducing anxiety. The study found that the 
winter cherry root extract prevents specific 
binding of GABA (3H) and TBPS (35s). 
An extract concentration of one mg 
completely hinders the binding. 
In operational studies of assessing 36CL 
flow in spinal neurons of mammals it was 
found that root extract of winter cherry 
plant increased 36CL flow in the absence 
of GABA. Such an effect is inhibited by 
bicuculine picrotoxin and is reinforced by 
diazepam. These results indicate that the 
extracts contain an element which has a 
GABA-like activity. In another study, anti-
depressants and anti-anxiety effect of 
bioactive glycowithanolides (WSG), 
extracted from WS roots were examined 
on rats and the results were compared with 
that of benzodiazepine lorazepam (0.5 
mg/kg) and tricyclic imipramine (10 
mg/kg) (4). It is probable that the extract 
acts on benzodiazepine receptors binding 
to GABA A receptors and causes an 
anxiolytic effect. To prove this, it is 
necessary to separate effective material of 
the plant and to conduct specific 
researches on each of these materials using 
other animal models to discriminate its 
sedative and anti-anxiety mechanisms. 
Hence, it requires further study to identify 
the chemical structure of the effective 
ingredients of the plant. The results 
showed that winter cherry root extract has 
anxiolytic effects while it reduces the 
locomotor activity. Plant extract at a dose 
of 75mg/kg has the same effect as 
diazepam, though it reduces locomotor 
activity.
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